This is filed to report a patient death.It was reported that on (b)(6) 2023 mitraclip procedure was performed to treat degenerative mitral regurgitation (mr) with grade 4+, and a prolapsed anterior leaflet.Two clips were successfully implanted, reducing mr to <1.On (b)(6) 2023, the patient passed away.It was noted after the procedure, the patient experienced functional hemodynamic disorders in the patient heart which included atrial fibrillation, ventricular tachycardia, weakened myocardial contractility, unsynchronized systolic times of the ventricles and atria, mitral insufficiency.The physician stated the implanted clips were stable on the leaflets, but implantation of the two clips eventually led to the heart becoming unstable.This resulted in heart failure, subsequently leading to death.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported shock, mitral stenosis, arrhythmia associated with the ventricular desynchrony, tachycardia associated with the ventricular tachycardia, atrial fibrillation, heart failure/congestive heart failure, and death / expired could not be determined.The reported patient effect of death, heart failure, arrhythmia, tachycardia, and atrial fibrillation, shock, and mitral stenosis, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design, or labeling.H6 device codes 2130 and 4451 removed.
|